Clinical Trial Update: PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial PReCedeNT comparing PRRT alone versus PRRT with chemotherapy for gastroenteropancreatic neuroendocrine tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor
• Neuroendocrine Neoplasms
• Neuroendocrine Tumor

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Neuroendocrine Neoplasia's (NENs), Neuroendocrine Tumor GEP Grade 1-3 | Phase 3 | Status: RECRUITING